http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2002512811-A
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6897 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01K67-027 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6897 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
filingDate | 1999-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2002-05-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | JP-2002512811-A |
titleOfInvention | Gene screening and related assays |
abstract | (57) [Summary] The present invention relates to a cell death gene which is a gene required for programmed cell death, a mutant organism in which ectopic programmed cell death occurs in an embryo to a greater extent than usual, and a programmed cell death of a cell. An agent that alters the ability to modulate. A Daktl mutant, Daktl q , in Drosophila melanogaster has been identified. Daktl and its mammalian homolog PKB are known to protect cells from apoptosis. The ability to genetically interact with mutants of Daktl describes a genetic screen to identify genes associated with programmed cell death. |
priorityDate | 1998-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 207.